Page last updated: 2024-11-01

nitrendipine and Leukemia P388

nitrendipine has been researched along with Leukemia P388 in 3 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kessel, D2
Wilberding, C1
Potemski, P1
Polakowski, P1

Other Studies

3 other studies available for nitrendipine and Leukemia P388

ArticleYear
Mode of action of calcium antagonists which alter anthracycline resistance.
    Biochemical pharmacology, 1984, Apr-01, Volume: 33, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Cell Line; Dau

1984
Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
    Archivum immunologiae et therapiae experimentalis, 1997, Volume: 45, Issue:2-3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Drug Resistance,

1997
Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Biochemical pharmacology, 1986, Aug-15, Volume: 35, Issue:16

    Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Daunorubicin;

1986